PEPFAR News and Research

RSS

New AIDS research training grants awarded for projects in 15 countries

The Fogarty International Center of the National Institutes of Health has awarded seven grants totaling almost $2.7 million to train HIV/AIDS researchers in 15 low- and middle-income countries.

14 Apr 2009

Stanford study shows PEPFAR program saved a million lives

The President's Emergency Plan for AIDS Relief, the ambitious U.S. government program begun in 2003, has cut the death toll from HIV/AIDS through 2007 by more than 10 percent in targeted countries in Africa, though it has had no appreciable effect on prevalence of the disease in those nations, according to a study from the Stanford University School of Medicine that is the first to evaluate these outcomes.

6 Apr 2009

U.S.-funded HIV/AIDS, malaria initiatives represent 'new approach' to foreign aid, opinion piece says

In her book "Dead Aid," author Dambisa Moyo comes to "disastrously wrongheaded conclusions" regarding U.S. foreign aid, columnist Michael Gerson writes in a Washington Post opinion piece.

5 Apr 2009

Mylan's Matrix receives tentative FDA approval under PEPFAR for generic Truvada

Mylan Inc. has announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.2% controlling interest, has received the first tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Emtricitabine and Tenofovir Disoproxil Fumarate Tablets, 200 mg/300 mg.

30 Mar 2009

Staggering new data shows TB-HIV co-infection a bigger threat

The World Health Organization released staggering new data about the threat of tuberculosis and the toll it takes on people with HIV/AIDS today, in recognition of World TB Day.

24 Mar 2009

Video game aims to teach young people in Kenya about HIV/AIDS prevention

A video game in Kenya -- called Pamoja Mtaani and launched through a partnership between Warner Bros. Entertainment and the President's Emergency Plan for AIDS Relief -- is teaching young people in the capital of Nairobi about HIV/AIDS risks and prevention strategies, VOA News reports.

5 Mar 2009

World Food Program expands program for HIV-positive people in Rwanda

The World Food Programme recently expanded a project in Rwanda that provides food to HIV-positive people taking antiretroviral drugs, adding 10,000 participants and increasing the number of project sites from 61 to 138 across 18 districts in the country, the New Times/AllAfrica.com reports.

4 Mar 2009

Global AIDS Alliance sounds alarm on potential budget cuts

Amid initial indications that the administration's first budget will flat-line funding for global health, the Global AIDS Alliance is calling on President Obama, Vice President Biden and Secretary of State Hillary Clinton to keep their campaign commitments to scale up the President's Emergency Plan for AIDS Relief (PEPFAR) and accelerate efforts to ensure every child around the world gets a free basic education.

23 Feb 2009

New Web-based tool for tracking blood safety

The Georgia Tech College of Computing, working in partnership with the Centers for Disease Control and Prevention, has developed a Web-based tool for tracking blood safety.

10 Dec 2008

AHF: Lancet’s Africa AIDS study shows global testing woefully under-funded

A study published in the British medical journal Lancet yesterday suggesting that testing all adults in Africa annually for HIV and immediately treating every person who tests positive could halt the AIDS epidemic in Africa within a decade has spurred the AIDS Healthcare Foundation (AHF) to renew its call for the massive scale up of, and dramatically increased funding for global HIV testing and antiretroviral treatment worldwide.

26 Nov 2008

FDA grants tentative approval for 75th generic anti-retroviral drug

The Food and Drug Administration within the U.S. Department of Health and Human Services (HHS) has reached the milestone of the 75th anti-retroviral generic drug approved or tentatively approved as part of President Bush's Emergency Plan for AIDS Relief (PEPFAR).

29 Oct 2008

Newspapers examine efforts, reaction to easing ban on HIV-positive visitors to U.S.

Some HIV/AIDS advocates are "being cautious with their optimism" regarding new immigration rules for HIV-positive visitors as well as HHS efforts to remove HIV from the list of diseases barring entry into the U.S., the San Francisco Chronicle reports (Fulbright, San Francisco Chronicle, 10/2).

5 Oct 2008

PEPFAR suspends funding for three Ranbaxy AIDS drugs banned by FDA

The President's Emergency Plan for AIDS Relief program has suspended funding for three antiretroviral drugs manufactured by Indian generic drugmaker Ranbaxy that were included in an importation ban imposed by FDA on Sept. 16, Bloomberg reports.

29 Sep 2008

HHS should act quickly to end travel restrictions for HIV-positive people, editorial says

HHS should take action "soon to end a de facto form of discrimination" by rewriting its rules prohibiting HIV-positive people from visiting the U.S., a Washington Post editorial says, adding that the continuation of the policy "puts the United States in the company of countries such as Libya, Saudi Arabia and Sudan."

29 Sep 2008

National Journal examines advocates,' lawmakers' efforts to create domestic HIV/AIDS plan

The National Journal on Saturday examined the efforts of some lawmakers and advocates to call for "renewed attention" to the HIV/AIDS epidemic in the U.S., including pushing for a national plan to address the epidemic.

24 Sep 2008

House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy

Rep. John Dingell (D-Mich.) and members of the House Committee on Energy and Commerce on Friday sent a letter to Secretary of State Condoleezza Rice requesting information about alleged safety problems with antiretrovirals manufactured by the Indian generic pharmaceutical company Ranbaxy and distributed through the President's Emergency Plan for AIDS Relief, the AP/International Herald Tribune reports (AP/International Herald Tribune, 9/19).

22 Sep 2008

House Democrats send letter to President Bush urging 'swift action' on reversal of rule banning HIV-positive foreigners from entering U.S.

Lawmakers and HIV advocates are urging the Bush administration to take action on reversing the current ban HIV-positive foreigners from entering the U.S., the AP/Los Angeles Times reports (Abrams, AP/Los Angeles Times, 9/20).

22 Sep 2008

Greater awareness of HIV/AIDS, other global health issues attributed to the growth in public health students

The Washington Post on Friday examined the "record numbers" of undergraduate college students who are taking classes in epidemiology, global health and public health, driven in part by the HIV/AIDS pandemic and a motivation to contribute to the field.

22 Sep 2008

Early antiretroviral treatment for people with HIV/TB coinfection could reduce mortality by half

People with HIV/tuberculosis coinfection who began antiretroviral treatment within six months of starting TB treatment had a 55% lower mortality rate than people with HIV/TB coinfection who did not begin antiretroviral therapy until after they had finished a six-month TB treatment course, according to a study conducted by researchers at the University of KwaZulu-Natal, Business Day reports (Kahn, Business Day, 9/18).

22 Sep 2008

U.S. needs national HIV/AIDS plan, should focus resources on epidemic's trends, opinion piece says

The recent CDC report on new HIV infections "underscore[s] ... the inexorable movement of the HIV/AIDS epidemic into black and other minority communities and the failure of government at all levels to respond to that change," C. Virginia Fields, president and CEO of the National Black Leadership Commission on AIDS, writes in a New York Daily News opinion piece (Fields, New York Daily News, 8/31).

2 Sep 2008

PEPFAR News and Research

New AIDS research training grants awarded for projects in 15 countries

Stanford study shows PEPFAR program saved a million lives

U.S.-funded HIV/AIDS, malaria initiatives represent 'new approach' to foreign aid, opinion piece says

Mylan's Matrix receives tentative FDA approval under PEPFAR for generic Truvada

Staggering new data shows TB-HIV co-infection a bigger threat

Video game aims to teach young people in Kenya about HIV/AIDS prevention

World Food Program expands program for HIV-positive people in Rwanda

Global AIDS Alliance sounds alarm on potential budget cuts

New Web-based tool for tracking blood safety

AHF: Lancet’s Africa AIDS study shows global testing woefully under-funded

FDA grants tentative approval for 75th generic anti-retroviral drug

Newspapers examine efforts, reaction to easing ban on HIV-positive visitors to U.S.

PEPFAR suspends funding for three Ranbaxy AIDS drugs banned by FDA

HHS should act quickly to end travel restrictions for HIV-positive people, editorial says

National Journal examines advocates,' lawmakers' efforts to create domestic HIV/AIDS plan

House members send letter to Condoleezza Rice requesting information on antiretrovirals supplied to PEPFAR by Ranbaxy

House Democrats send letter to President Bush urging 'swift action' on reversal of rule banning HIV-positive foreigners from entering U.S.

Greater awareness of HIV/AIDS, other global health issues attributed to the growth in public health students

Early antiretroviral treatment for people with HIV/TB coinfection could reduce mortality by half

U.S. needs national HIV/AIDS plan, should focus resources on epidemic's trends, opinion piece says

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News